{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:08:10Z","timestamp":1791382090166,"version":"4.3.3"},"reference-count":58,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Regional Development Fund","award":["KK.01.1.1.04.0115"],"award-info":[{"award-number":["KK.01.1.1.04.0115"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Kidney disease (KD) is a common complication of diabetes mellitus (DM) associated with adverse outcomes of renal failure, cardiovascular disease, and mortality. The aim of this study was to determine the prevalence and awareness of the KD among the DM type 2 (T2DM) patients. Materials and Methods: This cross-sectional study was conducted at the University Hospital of Split between November and December of 2023 during an open call for DM patients. For each participant, blood and urine samples, along with relevant medical information, were collected, and adherence to the Mediterranean diet (MeDi) was assessed using the Mediterranean Diet Service Score (MDSS). Furthermore, blood pressure was measured, along with body composition and anthropometric parameters. Results: Of 252 T2DM patients with a median age of 67 years (IQR: 60\u201373), 130 (51.6%) were women. The median duration of T2DM was 10 years (IQR: 6\u201320). Despite the fact that 80.95% of total participants reported receiving dietary guidelines from any source, only 53.2% reported adhering to the suggested instructions, while according to the MDSS, only 7.2% adhered to the MeDi. The median body mass index was 27.6 kg\/m2 (24.2\u201331), with 70.1% of participants overweight or obese. Only 6% of participants believed they had KD, but after blood and urine sample analysis, 31% were found to have KD. Conclusions: This study highlights a significant gap in awareness of KD, low adherence to MeDi, and a high prevalence of obesity among T2DM patients. Due to the increasing number of T2DM patients, it is crucial to improve healthy lifestyle education and make modifications within this group, as well as perform regular screening for KD and medical check-ups.<\/jats:p>","DOI":"10.3390\/medicina60101643","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T12:03:49Z","timestamp":1728389029000},"page":"1643","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Beyond Blood Sugar: Low Awareness of Kidney Disease among Type 2 Diabetes Mellitus Patients in Dalmatia\u2014Insights from the First Open Public Call"],"prefix":"10.3390","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2645-7597","authenticated-orcid":false,"given":"Josipa","family":"Radi\u0107","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology and Dialysis, University Hospital of Split, 21000 Split, Croatia"},{"name":"Internal Medicine Department, School of Medicine, University of Split, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijana","family":"Vu\u010dkovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology and Dialysis, University Hospital of Split, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2188-0006","authenticated-orcid":false,"given":"Hana","family":"\u0110oga\u0161","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Split, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2781-6280","authenticated-orcid":false,"given":"Marina","family":"Grubi\u0107","sequence":"additional","affiliation":[{"name":"Institute for Emergency Medicine of Split-Dalmatia County, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7848-6600","authenticated-orcid":false,"given":"Andrej","family":"Belan\u010di\u0107","sequence":"additional","affiliation":[{"name":"Department of Basic and Clinical Pharmacology with Toxicology, Faculty of Medicine, University of Rijeka, Bra\u0107e Branchetta 20, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leida","family":"Tandara","sequence":"additional","affiliation":[{"name":"Division of Medical Laboratory Diagnostic, University Hospital of Split, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucija","family":"\u0160oli\u0107 \u0160egvi\u0107","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology and Dialysis, University Hospital of Split, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Novak","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology and Dialysis, University Hospital of Split, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0350-6800","authenticated-orcid":false,"given":"Mislav","family":"Radi\u0107","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, School of Medicine, University of Split, 21000 Split, Croatia"},{"name":"Department of Internal Medicine, Division of Rheumatology, Allergology and Clinical Immunology, University Hospital of Split, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"key":"ref_1","unstructured":"WHO (2023). World Health Organization Diabetes, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1573403X1604201229115531","article-title":"Complications of the Type 2 Diabetes Mellitus","volume":"16","author":"Farmaki","year":"2021","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, Regional, and National Burden of Diabetes from 1990 to 2021, with Projections of Prevalence to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"(2022). Glycemic Targets: Standards of Medical Care in Diabetes\u20142022. Diabetes Care, 45, S83\u2013S96.","DOI":"10.2337\/dc22-S006"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1570161117666190405165151","article-title":"Macrovascular Complications of Type 2 Diabetes Mellitus","volume":"18","author":"Viigimaa","year":"2019","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/1570161117666190502103733","article-title":"Microvascular Complications of Type 2 Diabetes Mellitus","volume":"18","author":"Faselis","year":"2019","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2337\/dc17-1962","article-title":"Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030","volume":"41","author":"Bommer","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_9","unstructured":"(2024, September 24). Hrvatsko Dru\u0161tvo za Farmakoekonomiku i Ekonomiku Zdravstva Novi Podaci o Tro\u0161kovima Lije\u010denja \u0160e\u0107erne Bolesti u Hrvatskoj. Available online: https:\/\/www.jutarnji.hr\/specijal\/buducnost-zdravstva\/novi-podaci-o-troskovima-lijecenja-secerne-bolesti-u-hrvatskoj-cak-cetiri-milijarde-kuna-godisnje-hzzo-trosi-na-lijecenje-komplikacija-dijabetesa\/7095687\/."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"110945","DOI":"10.1016\/j.diabres.2023.110945","article-title":"Erratum to \u201cIDF Diabetes Atlas: Global, Regional and Country-Level Diabetes Prevalence Estimates for 2021 and Projections for 2045\u201d [Diabetes Res. Clin. Pract. 183 (2022) 109119]","volume":"204","author":"Sun","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4239\/wjd.v8.i4.120","article-title":"Type 2 Diabetes and Quality of Life","volume":"8","author":"Trikkalinou","year":"2017","journal-title":"World J. Diabetes"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Al Epidemiology of Type 2 Diabetes\u2014Global Burden of Disease and Forecasted Trends","volume":"10","author":"Khan","year":"2020","journal-title":"J. Epidemiol. Glob. Health"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrneph.2015.173","article-title":"Changing Epidemiology of Type 2 Diabetes Mellitus and Associated Chronic Kidney Disease","volume":"12","author":"Thomas","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Xie, D., Ma, T., Cui, H., Li, J., Zhang, A., Sheng, Z., and Xie, Y. (2023). Global Burden and Influencing Factors of Chronic Kidney Disease Due to Type 2 Diabetes in Adults Aged 20\u201359 Years, 1990\u20132019. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-47091-y"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"KDIGO Diabetes Work Group (2022). KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int., 102, S1\u2013S127.","DOI":"10.1016\/j.kint.2022.06.008"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1029358","DOI":"10.3389\/fpubh.2022.1029358","article-title":"Public Knowledge and Awareness of Diabetes Mellitus, Its Risk Factors, Complications, and Prevention Methods among Adults in Poland\u2014A 2022 Nationwide Cross-Sectional Survey","volume":"10","author":"Pinkas","year":"2022","journal-title":"Front. Public Health"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Kayyali, R., Slater, N., Sahi, A., Mepani, D., Lalji, K., and Abdallah, A. (2019). Type 2 Diabetes: How Informed Are the General Public? A Cross-Sectional Study Investigating Disease Awareness and Barriers to Communicating Knowledge in High-Risk Populations in London. BMC Public Health, 19.","DOI":"10.1186\/s12889-019-6460-7"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/diabetology4030031","article-title":"Current Obstacles (with solutions) in Type 2 Diabetes Management, Alongside Future Directions","volume":"4","year":"2023","journal-title":"Diabetology"},{"key":"ref_19","first-page":"3","article-title":"Hrvatske Smjernice Za Lije\u010denje Odraslih Osoba s Debljinom","volume":"76","year":"2022","journal-title":"Acta Medica Croat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3390\/nu6041406","article-title":"Mediterranean Diet and Diabetes: Prevention and Treatment","volume":"6","author":"Georgoulis","year":"2014","journal-title":"Nutrients"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3325\/cmj.2016.57.415","article-title":"Mediterranean Diet in the Southern Croatia\u2014Does It Still Exist?","volume":"57","author":"Relja","year":"2016","journal-title":"Croat. Med. J."},{"key":"ref_22","unstructured":"American Diabetes Association (2022). American Diabetes Association. American Diabetes Association (ADA) Diabetes Guidelines. Diabetes Care, 45, S17\u2013S38."},{"key":"ref_23","unstructured":"(2020, November 07). Mc780 User Manual. Available online: https:\/\/tanita.eu\/media\/pdf\/products-tanita\/professional\/MC-780\/MC-780MA%20N%20Instruction%20Manual%20%28EN%29%202018%20%282%29.pdf."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Marendi\u0107, M., Poli\u0107, N., Matek, H., Or\u0161uli\u0107, L., Pola\u0161ek, O., and Kol\u010di\u0107, I. (2021). Mediterranean Diet Assessment Challenges: Validation of the Croatian Version of the 14-Item Mediterranean Diet Serving Score (MDSS) Questionnaire. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0247269"},{"key":"ref_25","unstructured":"MedCalc (2022, June 06). MedCalc Statistical Software. Available online: https:\/\/www.medcalc.org\/."},{"key":"ref_26","unstructured":"IBM Corp (2019). IBM SPSS Statistics for Windows, version 26.0, IBM Corp."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.kint.2023.10.016","article-title":"Executive Summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: Known Knowns and Known Unknowns","volume":"105","author":"Levin","year":"2024","journal-title":"Kidney Int."},{"key":"ref_28","unstructured":"Vaidya, S.R., and Aeddula, N.R. (2024). Chronic Kidney Disease, StatPearls Publishing."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1001\/archinte.168.20.2268","article-title":"Patient Awareness of Chronic Kidney Disease","volume":"168","author":"Plantinga","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/med.21527","article-title":"Erythropoiesis and Chronic Kidney Disease\u2013Related Anemia: From Physiology to New Therapeutic Advancements","volume":"39","author":"Cernaro","year":"2019","journal-title":"Med. Res. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0002-9343(68)90254-4","article-title":"The Kidney and Erythropoiesis","volume":"44","author":"Adamson","year":"1968","journal-title":"Am. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/archinte.163.13.1555","article-title":"Effects of Blood Pressure Level on Progression of Diabetic Nephropathy: Results from the RENAAL Study","volume":"163","author":"Bakris","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Colbert, G.B., Elrggal, M.E., Gaddy, A., Madariaga, H.M., and Lerma, E.V. (2023). Management of Hypertension in Diabetic Kidney Disease. J. Clin. Med., 12.","DOI":"10.3390\/jcm12216868"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1111\/dom.14502","article-title":"High Concentrations of Triglycerides Are Associated with Diabetic Kidney Disease in New-Onset Type 2 Diabetes in China: Findings from the China Cardiometabolic Disease and Cancer Cohort (4C) Study","volume":"23","author":"Gong","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.12998\/wjcc.v12.i14.2308","article-title":"Neutrophil-to-Lymphocyte Ratio Associated with Renal Function in Type 2 Diabetic Patients","volume":"12","author":"Gao","year":"2024","journal-title":"World J. Clin. Cases"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Bu\u010dan Nenadi\u0107, D., Radi\u0107, J., Kolak, E., Vu\u010dkovi\u0107, M., Novak, I., Selak, M., and Radi\u0107, M. (2022). Mediterranean Diet Adherence and Nutritional Status in Dalmatian Diabetic Hypertensive Patients Regarding Presence of Chronic Kidney Disease\u2014Is There Any Difference?. Int. J. Environ. Res. Public. Health, 19.","DOI":"10.3390\/ijerph19042293"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Geri\u0107, M., Matkovi\u0107, K., Gajski, G., Rumbak, I., \u0160tancl, P., Karli\u0107, R., and Bituh, M. (2022). Adherence to Mediterranean Diet in Croatia: Lessons Learned Today for a Brighter Tomorrow. Nutrients, 14.","DOI":"10.3390\/nu14183725"},{"key":"ref_38","unstructured":"(2024, August 25). Eurostat Overweight and Obesity\u2014BMI Statistics\u2014Statistics Explained. Available online: https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=Overweight_and_obesity_-_BMI_statistics."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ruze, R., Liu, T., Zou, X., Song, J., Chen, Y., Xu, R., Yin, X., and Xu, Q. (2023). Obesity and Type 2 Diabetes Mellitus: Connections in Epidemiology, Pathogenesis, and Treatments. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1161521"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Zheng, C., Liu, Y., Xu, C., Zeng, S., Wang, Q., Guo, Y., Li, J., Li, S., Dong, M., and Luo, X. (2024). Association between Obesity and the Prevalence of Dyslipidemia in Middle-Aged and Older People: An Observational Study. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-62892-5"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ypmed.2015.04.023","article-title":"Healthy Eating Index and Metabolically Healthy Obesity in U.S. Adolescents and Adults","volume":"77","author":"Camhi","year":"2015","journal-title":"Prev. Med."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Sharma, S.P., Chung, H.J., Kim, H.J., and Hong, S.T. (2016). Paradoxical Effects of Fruit on Obesity. Nutrients, 8.","DOI":"10.3390\/nu8100633"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/nutrit\/nuab053","article-title":"Nut Consumption, Body Weight, and Adiposity in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"80","year":"2022","journal-title":"Nutr. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and Cardiovascular Outcomes in Type 2 Diabetes (REWIND): A Double-Blind, Randomised Placebo-Controlled Trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e12439","DOI":"10.1111\/cob.12439","article-title":"Glucagon-like Peptide-1 Receptor Agonists in the Era of COVID-19: Friend or Foe?","volume":"11","year":"2021","journal-title":"Clin. Obes."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e076410","DOI":"10.1136\/bmj-2023-076410","article-title":"Comparative Effectiveness of GLP-1 Receptor Agonists on Glycaemic Control, Body Weight, and Lipid Profile for Type 2 Diabetes: Systematic Review and Network Meta-Analysis","volume":"384","author":"Yao","year":"2024","journal-title":"BMJ"},{"key":"ref_50","unstructured":"(2024, August 22). HZZO Objavljene Liste Lijekova. Available online: https:\/\/hzzo.hr\/poslovni-subjekti\/zdravstvena-zastita\/lijekovi\/objavljene-liste-lijekova."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/diabetology4030022","article-title":"Sodium-Glucose Co-Transporter 2 Inhibitors as a Powerful Cardioprotective and Renoprotective Tool: Overview of Clinical Trials and Mechanisms","volume":"4","year":"2023","journal-title":"Diabetology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Salvatore, T., Galiero, R., Caturano, A., Rinaldi, L., Di Martino, A., Albanese, G., Di Salvo, J., Epifani, R., Marfella, R., and Docimo, G. (2022). An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073651"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in Patients with Chronic Kidney Disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"The EMPA-KIDNEY Collaborative Group (2023). Empagliflozin in Patients with Chronic Kidney Disease. N. Engl. J. Med., 388, 117\u2013127.","DOI":"10.1056\/NEJMoa2204233"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(22)02074-8","article-title":"Impact of Diabetes on the Effects of Sodium Glucose Co-Transporter-2 Inhibitors on Kidney Outcomes: Collaborative Meta-Analysis of Large Placebo-Controlled Trials","volume":"400","author":"Baigent","year":"2022","journal-title":"Lancet"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e023811","DOI":"10.1161\/JAHA.121.023811","article-title":"National Trends in Use of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020","volume":"11","author":"Adhikari","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12933-020-01154-w","article-title":"Worldwide Inertia to the Use of Cardiorenal Protective Glucose-Lowering Drugs (SGLT2i and GLP-1 RA) in High-Risk Patients with Type 2 Diabetes","volume":"19","author":"Schernthaner","year":"2020","journal-title":"Cardiovasc. Diabetol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/10\/1643\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:09:09Z","timestamp":1760112549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/10\/1643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":58,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["medicina60101643"],"URL":"https:\/\/doi.org\/10.3390\/medicina60101643","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,8]]}}}